Transcript Highlights:

• ...to a pharmacy in one month.
• And that's part of our model is to have that contract, provide that contract oversight.
• Pharmacy fraud. Give me that one. So pharmacy fraud would be, you know, pill mills.
• they're paid by the pharmacy.
• for the pharmacy that it owns.

Keywords: 1185, senate, all

Transcript Highlights:

• We are the national trade association for pharmacy benefit managers, and pharmacy benefit managers are
• We are a pharmacy with rural rates, and so we are different than most pharmacies because we don't have
• any pharmacies that are near us.
• of their pharmacies.
• of your office we would be contracting of your office we would be contracting it<02:38:52.520>

Keywords: 910, house, all

Summary: The committee first took up SB 1494 on hearing aids. Testimony was generally supportive of expanding hearing-aid coverage, with the Insurance Division raising concern about possible federal defrayment issues, SHPDA supporting the goal of hearing augmentation, DCAB strongly supporting the bill as an important access issue, and health plans and insurers asking for amendments. Kaiser Permanente and the Hawaii Association of Health Plans requested changes to add a medical-necessity standard and clarify annual notice language, while HMSA suggested the proposal should be studied by the auditor. The chair noted concerns about federal preemption and the lack of an audit, and deferred the bill in favor of a related resolution calling for a study. The committee then heard SB 1448, an emergency appropriation for the Hawaii State Hospital. DAGS and the Department of Health supported the measure, with the hospital administrator saying the funding would improve the environment of care, support cleaning, and allow a third-party review of the building. Committee members questioned the size of the request and the status of litigation against the design-builder. Administration witnesses said they were pursuing a comprehensive study involving destructive testing, had made a demand on the design-builder to fund the study, and were using different processes than before. They also said the roof work would be handled through a separate CIP request. No final action was taken in the portion provided. The committee next heard SB 1432, relating to the future responsibilities of the Department of Health and land issues at Kalaupapa after the last patient dies. DOH supported the bill in part but said its long-term role would be limited mainly to environmental cleanup, with operations expected to continue under the National Park Service and land-use decisions left to DHHL and beneficiary consultation. DHHL asked that the measure reflect that any land-use or zoning changes on homeland lands require commission approval and beneficiary consultation. Testifiers from Kalaupapa and Maui County, including Degra Vanderbilt-Papa and Council Member Keani Rollins-Fernandez, supported deferring the bill, saying there had been no meaningful community discussion about provisions affecting Kalaupapa’s future management and possible transfer of responsibilities to Maui County. The committee also read into the record written testimony from Gloria Marks emphasizing that Kalaupapa stakeholders must be included in future discussions. Finally, the committee heard SB 955 on fitness-to-proceed examinations. The Judiciary and the Public Defender’s Office both supported raising pay and standardizing expectations for private examiners, but opposed reducing felony fitness evaluations from three examiners to one and opposed expanding use of expedited reports. They argued that a single examiner would reduce reliability, create a more adversarial process, and likely increase costs and contested hearings, while expedited reports do not contain enough information for a proper fitness determination. The Department of Health also supported the bill’s intent but asked to preserve a three-examiner framework and said the goal was to reduce the number of people sent to the State Hospital, where admissions have reportedly risen about 20% year over year since Act 26. The bill remained under discussion in the excerpt, with no final vote shown.

Transcript Highlights:

• I understand the definition of contract pharmacy is different.
• understand the definition of contract understand the definition of contract Pharmacy<00:04:39.440
• > and to contract with outside pharmacies and to contract with outside pharmacies and the<00:20
• <00:20:57.159> pharmacies<00:20:57.919> does<00:20:58.080> that outside contract
• pharmacies does that outside contract pharmacies does that make<00:20:58.360> sense I<00:21:01.960

Keywords: 00:25 Call to Order/Roll Call 01:36 Discussion of 25RS SB 153 23:11 Roll Call Vote on 25RS SB 153 30:56 Adjournment, 958, all

Summary: The House Standing Committee on Health Services met on March 14, 2025, and took up a committee substitute for Senate Bill 153. The substitute deleted the original bill language and replaced it with provisions from Senate Bill 14, aimed at prohibiting pharmaceutical manufacturers from discriminating against 340B covered entities and adding reporting requirements for those entities. The sponsor explained that the protections would sunset after one year, allowing lawmakers to review data by July 1, 2026, and that Kentucky would continue to follow any future federal changes to the 340B program. Members asked several questions about the scope of the reporting, including what “total operating cost” means, how duplicate discounts are prevented, whether the reporting applies only to hospitals and not federally qualified health centers, and who would receive the data. The sponsor said the reporting is intended to help the Cabinet for Health and Family Services and the Office of Health Data Analytics at LRC assess how the program is working, including charity care and community benefits, while preserving protections for rural hospitals and allowing them to continue using contract pharmacies. A representative from LRC confirmed the data would come to the General Assembly through the Office of Health Data Analytics. The committee expressed mixed views about the balance between transparency and potential burdens on hospitals, especially rural facilities. Several members said they were supportive but had reservations about the reporting requirements and the sunset structure, while others noted concerns about unintended consequences and the possibility of changes on the House floor. The committee ultimately adopted the committee substitute, approved a title amendment, and reported Senate Bill 153 with House Committee Substitute 2 favorably. The meeting then adjourned.

Transcript Highlights:

• And I appreciate the consideration around contract labor.
• And I appreciate the consideration around contract labor.
• And I appreciate the consideration around contract labor.
• Additionally, this bill requires new restrictions on how PBMs operate their contract and pharmacy networks
• , prohibiting discrimination against non-affiliated pharmacies, and requiring PBMs to include any pharmacy

Keywords: 988, house, all

Transcript Highlights:

• Hospitals are doing better when they're reducing costs, including reliance on contract labor.
• I appreciate the consideration around contract labor.
• SB 41 builds upon the previously established pharmacy benefit manager...
• Additionally, this bill requires new restrictions on how PBMs operate their contracted pharmacy networks
• , prohibiting discrimination against non-affiliated pharmacies and requiring PBMs to include any pharmacy

Summary: The Assembly Budget Subcommittee on Health heard updates on five health-related budget items. First, members reviewed state support for distressed hospitals and health facilities. The California Health Facilities Financing Authority and HCAI described the Distressed Hospital Loan Program as a lifeline for 16 hospitals, many of which remain financially strained and are expected to seek loan forgiveness rather than repayment. Speakers cited reduced contract labor, new service lines, strategic partnerships, and the reopening of Madera Hospital as signs of progress, but also warned that federal policy changes under H.R. 1 will likely increase uncompensated care and pressure emergency departments. Public commenters from hospital, dental, and consumer groups supported additional funding, including a request to refresh the program with another $300 million. The committee then heard HCAI’s update on the California Rural Health Transformation Program, a five-year federal initiative funded at $233.6 million for California. HCAI said the program will focus on rural care models, workforce development, and health technology, with grants to be rolled out on a fast timeline and all funds obligated by October 30, 2026. Members raised concerns about rural provider capacity to apply for grants, and HCAI said it will use a third-party administrator, a technical assistance center, webinars, and other supports to help applicants. HCAI also presented its budget request for the health care payments database, seeking ongoing non-General Fund support to continue operations and expand data, including pharmacy benefit manager data. The Emergency Medical Services Authority presented three budget change proposals: funding to replace disaster medical services fleet vehicles, funding for IT security work, and additional positions for HR, enforcement, and legal workload. A member also raised concern that EMSA has not yet completed the annual ambulance rate reporting required by AB 716, and EMSA said it remains committed to the requirement but lost prior funding through later budget reductions. Covered California reported that it is still finalizing its own budget, but expects a lower operating budget due to efforts to reduce baseline costs and align spending with actual expenditures; it also projected enrollment declines tied to the expiration of enhanced premium tax credits, H.R. 1, and federal rule changes, while noting that revenues may still rise because premiums are expected to increase. Finally, the Department of Managed Health Care outlined budget proposals tied to menopause coverage and education, PBM licensure and enforcement under AB 116 and SB 41, credentialing reforms under AB 1041, and prior authorization reporting under SB 306. Public testimony generally supported the menopause and PBM proposals, while also urging clearer language and attention to Medi-Cal parity. The hearing concluded after public comment, including additional advocacy for sickle cell services and rural health workforce funding.

Transcript Highlights:

• Number two, the aggregate amount paid to pharmacies that are owned or affiliated with the pharmacy benefit
• Number three, the aggregate amount paid to pharmacies that are not owned or affiliated with the pharmacy
• Number five, disclose contract policies that reduced reimbursement to pharmacies for their participation
• Number six, the aggregate amount showing 340B contract rate reductions to pharmacies.
• You could have contract pharmacies, you could have FQHCs.

Keywords: 908, all

Summary: The committee first addressed Senate Bill 2387, which had previously included language expanding the definition of a sexual assault victim advocate to include advocates from organizations serving victims of sexual trafficking or other sexual violence. After concerns were raised that the language could broaden participation in forensic interviews beyond appropriately credentialed organizations, the parties agreed to remove that added language. The committee then reconsidered its prior action, adopted the amendment striking the new language, and passed SB 2387 as amended on a 12-0-1 roll call vote. The bulk of the meeting focused on Representative Nelson’s proposed changes to a 340B-related bill, centered on expanding reporting and transparency requirements. His draft would require hospitals to report how 340B savings are used, and would also add reporting by drug manufacturers, pharmacy benefit managers, and health insurers on rebates, pricing, ownership interests, 340B savings, premiums, claims, and related data. Nelson argued the reporting was needed to give lawmakers better information about how the 340B program affects hospitals, insurers, pharmacies, and public costs, and noted the Department of Corrections also benefits from the program. Testimony was mixed but generally supportive of more transparency. Sanford Health Plan said it needed more time to review carrier impacts and had concerns about employer-related language and rebate reporting. The North Dakota Hospital Association supported hospital transparency and said the broader approach was appropriate because hospitals are only one part of the 340B system. Several members raised procedural concerns about the scope of the proposal and the lack of a drafted LC amendment. The committee decided not to take final action on the 340B proposal that day, instead forming a subcommittee led by Representative Hendricks, with Representatives Dobervich and Bolinske, to work with LC and return with drafted language for further review on Monday.

Transcript Highlights:

• The PBM must make the pharmacy whole.
• The PBM must make the pharmacy whole.
• The PBM must make the pharmacy whole.
• And are you representing the pharmacies, independent pharmacies? Thank you, Matthew.
• away from her local pharmacy.

Bills: SB25, SB250, HB22, HB27, HB33, HB47, HB233, HB290, HB308, HB324, HB382, HB533, HB559, HB575, HB980, HB1157, HB1207, HB1236, HCR45

Keywords: registrar of voters, parish registrar, chief deputy registrar, confidential assistant, election administration, elections, salary schedule, compensation, merit evaluation, population-based pay, census-based pay, Department of State, Secretary of State, State Board of Election Supervisors, redistricting, senate districts, Senate District 33, Senate District 34, Senate District 35, precincts

Transcript Highlights:

• It is the review of an EBD contract with Boston Consulting Group. This is a contract for $280,000.
• So with that, I need a motion to review the contract. I have a second.
• Next item up is the January 2026 pharmacy formulary recommendations.
• Next item up is the January 2026 pharmacy formulary recommendations.
• Moving to the February 2026 pharmacy formulary recommendations.

Summary: The State Insurance Programs Oversight Subcommittee met to review and approve several Employee Benefits Division (EBD) and pharmacy formulary actions. Grant Wallace, director of EBD and the Office of Property Risk, presented a $280,000 Boston Consulting Group contract to help develop the third-party administration RFP, and the committee approved it. The committee also approved the December 2025, January 2026, and February 2026 pharmacy formulary recommendations, along with February 2026 medical drug recommendations. The formulary changes focused on removing prior authorization for injectable migraine CGRPs, replacing a discontinued capsule with a tablet, updating items for FDA guidance, and leaving some drugs not covered when lower-cost alternatives or insufficient efficacy data existed. For February 2026, EBD recommended removing Skyrizi and Renvoke in favor of lower-cost biosimilars and other alternatives, re-tiering several drugs to encourage generics, adding an anti-seizure medication developed by the Department of Defense, and adding a subcutaneous version of Keytruda for faster administration. The medical drug list similarly shifted toward biosimilars and aligned coverage for Skyrizi and Renvoke across pharmacy and medical settings. Members raised broader questions about the impact of new pharmaceutical discount programs such as Trump RX and Mark Cuban Cost Plus, as well as concerns about PBM compliance and whether Navitus might be violating state law or paying affiliate pharmacies more than independent pharmacies. Wallace said the new programs and their effects were still being studied, that EBD was working with Navitus to evaluate pricing opportunities, and that Navitus had said it was in compliance with Rule 118, though additional research and auditing were underway. All items were approved by voice vote, and the meeting adjourned after no further business.

Transcript Highlights:

• At that time, when I was contracted, they contracted me at 67% of the fee schedule, which a physician
• And then you have to try and find an independent pharmacy.
• I have a special-needs child, and not every pharmacy does carry everything.
• And then you have to try and find an independent pharmacy.
• And I've literally gone between two pharmacies on the same street.

Summary: The committee took up a large health and human services agenda and first approved HB 711, the Spectrum Alert bill, which would create a statewide alert system for missing autistic children and require FDLE to coordinate training with state and local agencies. The measure drew a supportive waiver from the Florida Smart Justice Alliance and passed unanimously, 24-0, reported favorably. Members then considered CS for HB 229 on health facilities, which modernizes the Health Facilities Authority Act to allow additional nonprofit health system structures to use tax-exempt financing. Two amendments were adopted: one requiring advance notice, public hearings, and stakeholder notifications before a nonprofit hospital closure, and another removing a property tax exemption for a nonprofit hospital that closes and fails to maintain emergency services for 120 days, applied retroactively to January 1, 2025. The Florida Hospital Association opposed the amendments, citing workforce and nonprofit-status concerns, but the bill as amended passed 24-0. The committee also approved CS for HB 1405 on juvenile justice status offenders, expanding early truancy intervention, parent involvement, and shelter placement review timelines; it passed 24-0. CS for HB 27, joining the Social Work Licensure Interstate Compact, and its linked public records bill CS for HB 29 both passed unanimously after supportive testimony from several advocacy and business groups. The committee then debated HB 111 on out-of-network referrals and HB 1083 on patient access to records. HB 111 would require referring practitioners to inform patients in writing when a referral is out of network and to apply out-of-network payments to deductibles; it drew opposition from medical groups over administrative burden and patient-care concerns, but passed 17-8. HB 1083 would shorten the time for producing medical records to 14 working days and standardize access rules, with amendments clarifying portal access and delaying the effective date to January 1, 2026; despite opposition from some health information and provider groups over HIPAA and access concerns, it passed 19-7 as amended. Later, the committee approved HB 883, allowing autonomous practice for psychiatric nurse practitioners with the required credentials, after strong support from nurse practitioner groups and opposition from psychiatric and medical associations; it passed 23-3. HB 1297, which aligns Florida’s electronic prescribing exceptions with federal law and removes several state exemptions, passed 19-7 despite opposition from hospice, emergency physician, rheumatology, and medical groups concerned about paper prescriptions in emergencies and hard-to-find medications. HB 1353 on home health care services and CS for HB 989 on foster home licensure transfers both passed unanimously after supportive amendments. The committee also heard HB 1505 on parental rights, which would require written parental consent for many health care services, surveys, and biofeedback devices for minors and expand parental access to records; the bill drew extensive support testimony but also questions and concerns about confidentiality, abuse reporting, and existing exceptions, and the transcript ended before a final vote on that bill.

Transcript Highlights:

• Children cannot legally contract with these companies.
• But when all apps are viewed in regards to contracts, and we look at this from contract law, if every
• contract with an app, which they currently are, and then you just require all apps to contract with
• Not only do they regulate the practice of pharmacies, so pharmacists and their pharmacies, they also
• Not only do they regulate the practice of pharmacies, so pharmacists and their pharmacies, they also

Bills: SB1176, SB1186, SB1235, SB1286, SB1446, SB1458, SB1515, SB1616, SB1641, SB1668, SB1670, SB1678, SB1747, SB1787

Keywords: stormwater, water storage, replenishment credits, groundwater, aquifer, Arizona Revised Statutes, disclosure, state contracts, procurement records, donations, transparency, EMS, reciprocity, interstate compact, paramedics, emergency medical technicians, licensure, public safety, military personnel, veterinary telemedicine

Transcript Highlights:

• the hospital under the hospital pharmacy the hospital under the hospital pharmacy rate<00:24:28.200
• <00:24:48.520> benefit been build under the pharmacy benefit been build under the pharmacy
• <00:33:18.240> which position to the Board of Pharmacy which position to the Board of Pharmacy
• I can't answer—I don't negotiate those contracts, the state does negotiate those contracts—but help me
• <02:50:30.479> issue Contracting and so the Contracting issue Contracting and so the Contracting

Keywords: 1191, senate, all

Transcript Highlights:

• <01:37:28.719> at made up of the College of Pharmacy at made up of the College of Pharmacy
• > testimony community pharmacy testim testimony community pharmacy testim testimony recently,<
• pharmacy or pharmacy services near it. pharmacy or pharmacy services near it.
• Medical Assistance Directed Pharmacy Medical Assistance Directed Pharmacy Payment<01:38:32.719><
• single PBM model or really a pharmacy single PBM model or really a pharmacy benefit<01:39:01.199

Keywords: 1187, senate, all

Transcript Highlights:

• It is the review of an EBD contract with Boston Consulting Group. This is a contract for $280,000.
• So with that, I need a motion to review the contract. I have a second.
• Next item up is the January 2026 pharmacy formulary recommendations.
• Next item up is the January 2026 pharmacy formulary recommendations.
• Moving to the February 2026 pharmacy formulary recommendations.

Summary: The State Insurance Programs Oversight Subcommittee met to review and approve several State Board of Finance actions related to employee benefits and pharmacy coverage. Grant Wallace, Director of the Employee Benefits Division and Office of Property Risk, presented a $280,000 Boston Consulting Group contract to help develop a third-party administration RFP, and the committee approved it. The committee then considered pharmacy formulary recommendations for December 2025, January 2026, and February 2026, along with February 2026 medical drug recommendations. Across the formulary items, Wallace explained that some drugs were being removed from prior authorization requirements, some were being updated to reflect FDA guidance or dosage changes, and others were being left not covered because lower-cost alternatives already exist or clinical evidence was insufficient. Notable changes included removing Skyrizi and Renvoke from the pharmacy formulary in favor of lower-cost biosimilars, adding certain generics, and adding a subcutaneous version of Keytruda for faster administration. The committee approved each set of recommendations by motion and voice vote. Members also raised broader questions about the impact of new drug-pricing programs such as Trump RX, Cost Plus, and other manufacturer discount efforts, as well as concerns about PBM oversight and whether Navitus is complying with state law. Wallace said the department is still studying those issues and working with Navitus to assess pricing opportunities and compliance. Senator Boyd also asked about whether affiliated pharmacies are being paid more than independent pharmacies, noting he had not received a prior response; Wallace was asked to follow up. The meeting concluded with no further business and adjournment.

Transcript Highlights:

• The State Board of Pharmacy provides that as long as they act in a reasonable and prudent manner.
• Whether it's in a shop or in a pharmacy, people need care, and we aren't meeting it.
• to determine whether or not he or she is guilty of a crime related to the contract.
• House Bill 26, relating to contracting with law enforcement agencies in certain counties.
• In my county, not a single one of these contracts has ever been denied.

Bills: SB 3, SB 16, SB 2, SB 5, SB 10, HB17, SB 54, SB 9, SB 7, SB 17, SB 4, HB8, HB25, HB26, HB192, HB8, HB25, HB26, HB48, HB149, HB192, HB254, HB17, SB54, SB9, SB7, SB17, SB4, SB3, SB16, SB2, SB5, SB10

Keywords: flash flood, flood warning, outdoor warning siren, emergency alert, disaster preparedness, flood mitigation, Hill Country floods, Texas Water Development Board, municipalities, counties, local government mandate, public safety, grant program, backup power, weather siren, emergency management, flood-prone area, warning system, real property theft, real property fraud

Transcript Highlights:

• five years ago we had to sign contracts five years ago we had to sign contracts at<00:40:17.720>
• community pharmacies and independent pharmacies, least of which are very below-cost dispensing fees.
• community pharmacies and independent pharmacies, least of which are very below-cost dispensing fees.
• <01:21:24.000> benefit pharmacy benefit pharmacy benefit in<01:21:25.199> particular<01
• This contract is personal for me.

Keywords: 1183, house

Transcript Highlights:

• rules that go into effect that directly contradicts the law that we passed last year on the pharmacy
• Chair. >> Roberts, does this address at all emergency contracts because on contract review we are having
• I was trying to find the verbiage here. uh in the pharmacy board where in uh in the pharmacy board where
• year on the pharmacy board. year on the pharmacy board. um<00:11:29.279> the<00:11:29.760
• emergency contracts emergency contracts because<00:12:24.240> on<00:12:25.040> contract

Bills: HB59, SB15, SB96, SB104, SB137

Keywords: public accountancy, CPA licensing, board regulations, educational prerequisites, electronic notifications, firm registration, assignment, creditors, insolvency, liquidation, assignee, secured transaction, bankruptcy, state law, voluntary process, distribution of assets, emergency rules, governor certification, state regulations, public safety

Transcript Highlights:

• Even after the contracts were awarded, there was a lot more time needed.
• right in the middle of these contracts.
• However, funding that now will be slashed even though it's mid-contract.
• Is it going to be contracted out? It will be contracted out.
• It would also be grouped by pharmacies owned and not owned by the pharmacy benefit manager.

Keywords: 988, house, all

Transcript Highlights:

• Today, many benefit contracts are complicated and restrictive.
• Nick Cahan, Professional Arts Pharmacy, president, in support, do not wish to speak.
• Nick Waltz, Louisiana Compound Pharmacy Coalition.
• Rachel Grosafco, Louisiana Compound Pharmacy Coalition.
• Louisiana Compound Pharmacy Coalition.

Bills: SCR37, SB145, SB237

Keywords: informed consent, healthcare, medical procedures, patient rights, surgeon general, regulatory review, adult residential care, generators, emergency power, health safety, Louisiana Department of Health, compliance, regulations, child welfare, Department of Children and Family Services, mandatory reporting, abuse prevention, investigative teams, child ombudsman, forensic interviews

Summary: The House Committee on Health and Welfare met on April 28 with a quorum and took up several health-related bills. SB 113, concerning the local health care provider participation program in Calcasieu Parish, was amended with a technical set and reported favorably with amendments after the author explained it would shift the local sponsor from the parish to the city. SB 23, which exempts certain assisted living facilities from the definition of food service establishment, was reported favorably. SB 150, allowing LDH to scan and return supporting documents for vital records changes, was also reported favorably. SB 221, which would allow EMS providers to be reimbursed by Medicaid for treating patients on scene without transport, drew questions about billing, coding, and implementation but was reported favorably, with members noting it could reduce unnecessary ER use and costs.

Transcript Highlights:

• Was that contract competitively bid since it was a contract over $35,000?"
• We've collapsed specialty contracts into a single complete contract.
• Contracts into a single complete contract. We've moved behavioral services into managed care.
• with pharmacy networks.
• Barney Bishop, Small Business Pharmacies. Small Business Pharmacies.

Summary: The committee first heard Senate Bill 1414 by Sen. Polsky on congenital cytomegalovirus (CMV) education. The bill would require the Department of Health, working with medical experts, to create and distribute CMV educational materials to expectant and new parents or caregivers through hospitals, birth centers, and OB/GYN practices. An amendment removed a section that would have required instruction for medical professionals, and the amended bill was reported favorably as a committee substitute. The committee then took up a block of confirmations. Appointees on tabs 2 through 7 were recommended favorably in one vote, and Chavon Harris was separately confirmed as Secretary of the Agency for Health Care Administration after extensive questioning. Senators praised her leadership and experience, while others raised concerns about Medicaid redeterminations, the state’s CORE modernization project, Hope Florida, and a DCF anti-marijuana ad campaign; Harris said she would follow up on some issues and defended the agency’s work on transparency, managed care oversight, and access to care. Her confirmation was recommended favorably, with Sen. Berman noting opposition. Several health-related bills were then heard and advanced. SB 186 by Sen. Garcia expanded epilepsy training requirements for school personnel, including charter school bus drivers, and was reported favorably. SB 902 by Sen. Garcia, after amendments narrowing dental workforce provisions and allowing certain seizure rescue medication delegation to family home health aides, was reported favorably; testimony focused on medical marijuana regulation, practitioner accountability, and concerns about park and child-care proximity restrictions. SB 196 by Sen. Sharif created a uterine fibroid research database with privacy protections and was reported favorably after emotional testimony from a patient and supporters. SB 688 by Sen. Rodriguez would reestablish licensure of naturopathic doctors; it drew both support and skepticism about diagnosis and treatment boundaries, but was reported favorably. SB 1574, Maddie’s Law, would add biliary atresia screening to newborn screening and was strongly supported by parents describing a delayed diagnosis; it was reported favorably. SB 878 on clinical laboratory personnel, SB 1092 on podiatric medicine and certain cellular/tissue-based products, and SB 1032 on medical marijuana registry timelines and veteran fee waivers were also reported favorably, while SB 1032 drew debate over longer renewal/supply periods. The committee then began SB 1760 on Medicaid oversight and program transparency, with the sponsor describing the bill’s creation of a joint legislative oversight committee and a legislative actuary.

Transcript Highlights:

• It took a long time for the contracts to get out. Even after the contracts were awarded...
• It took a long time for the contracts to get out, even after the contracts were awarded, a lot more time
• CRDP programs, I echo the chair's concerns around these cuts, particularly in the middle of their contracts—contracts
• Is it going to be contracted out? It will be contracted out.
• It would also be grouped by pharmacies owned and not owned by the pharmacy benefit manager.

Summary: The Assembly Budget Subcommittee on Health held an informational hearing on the Governor’s May Revision, focusing first on the Commission on Behavioral Health, then EMSA, and then the California Department of Public Health (CDPH). The Department of Finance said the state faces a third consecutive deficit and that the May Revision includes difficult trade-offs, including proposed eliminations or reversions of some behavioral health and public health funds. The LAO echoed concern about the structural deficit and said it was still awaiting some budget details before offering a full analysis. For the Commission on Behavioral Health, Finance proposed eliminating $20 million in Mental Health Wellness Act funds, arguing the money would help offset General Fund costs and noting future Proposition 1 innovation funding. The commission strongly opposed the cut, saying it would eliminate or delay launch-ready grants for early childhood supports, full-service partnerships, and peer respite, and would eventually end ongoing grant programming. Several advocates and commissioners testified that the funds support underserved communities and that Proposition 1 is not a substitute for the existing programs. The chair asked Finance to look for alternatives, but no vote was taken. EMSA presented mostly technical budget adjustments: increased authority for the California Poison Control System, a correction to EMSIS funding, and a reappropriation for enterprise services and data management. CDPH then reviewed a broader set of May Revision proposals, including reversions from the California Reducing Disparities Project, workforce development, STD prevention, hepatitis C prevention, hospice, and extreme heat funding, as well as a new generative AI pilot for health facility survey reporting. Members raised concerns about cuts to CRDP and gender health equity programs, especially because many grants are mid-contract and serve underserved communities; CDPH said the reversions were part of solving the deficit and that CRDP had been successful, while also clarifying that abortion.ca.gov would not be eliminated. Public comment was overwhelmingly opposed to the CRDP and related cuts, with many speakers describing the programs as life-saving and cost-effective. No formal votes or actions were taken during the hearing.